BioView develops, manufactures and assembles, markets and services innovative automated cell diagnostic systems for use in cytology, cytogenetics, hematology and pathology laboratories. BioView offers automated scanning solutions to scan FISH UroVysion slides used in the detection of Bladder Cancer, FISH PathVysion for Her2/Neu detection as well as hematological and other onclogy related disorders.
BioView also has applications for detecting prenatal and postnatal abnormalities.
The Company is the leading supplier of systems to commercial laboratories, hospital based clinical and research laboratories.
The Company also is developing proprietary genetic-based tests for the early detection of Lung Cancer.
The Company’s unique Target- FISH (T-FISH) technology combines morphological and genetic information on the same cell. This technology help the caregivers to offer more sensitive and specific test results for early detection and follow up of cancer.